4.7 Article

Total Bilirubin Yields Prognostic Information Following a Myocardial Infarction in the Elderly

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

Bilirubin Levels Are Negatively Correlated with Adiposity in Obese Men and Women, and Its Catabolized Product, Urobilin, Is Positively Associated with Insulin Resistance

Zachary A. Kipp et al.

Summary: This study found that bilirubin levels are lower in obese individuals compared to lean individuals. Obesity leads to an increase in the UGT1A1 enzyme, which clears bilirubin from the blood. As a result, more conjugated bilirubin enters the intestine and is converted into urobilin, which is then absorbed through the hepatic portal vein. The study also revealed a negative correlation between bilirubin levels and BMI and adiposity in obese individuals, while urobilin levels were positively associated with BMI and adiposity. Obese women were found to have higher insulin resistance, and urobilin levels showed a stronger linear correlation with insulin resistance in women compared to men. These findings suggest that plasma urobilin levels are associated with obesity and its comorbidities such as insulin resistance.

ANTIOXIDANTS (2023)

Review Peripheral Vascular Disease

Dose-Response Association Between Bilirubin and Cardiovascular Disease: A Systematic Review and Meta-analysis

Lei Zuo et al.

Summary: The association between bilirubin and cardiovascular disease remains controversial. This meta-analysis found a U-shaped dose-response relationship between bilirubin and CVD, especially for men.

ANGIOLOGY (2022)

Review Endocrinology & Metabolism

Bilirubin as a metabolic hormone: the physiological relevance of low levels

Justin F. Creeden et al.

Summary: Recent research indicates that bilirubin may have a new role as a metabolic hormone, potentially leading to cardiovascular complications for patients with low levels. Protective mechanisms at mildly elevated levels of bilirubin could offer treatment possibilities for those with hypobilirubinemia.

AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2021)

Article Cardiac & Cardiovascular Systems

Effects of n-3 Fatty Acid Supplements in Elderly Patients After Myocardial Infarction A Randomized, Controlled Trial

Are Annesonn Kalstad et al.

Summary: The addition of 1.8g n-3 PUFA to standard care did not result in a significant reduction in cardiovascular events during a 2-year follow-up in elderly patients with recent AMI.

CIRCULATION (2021)

Article Medical Laboratory Technology

Serum bilirubin improves the risk predictions of cardiovascular and total death in diabetic patients

Su-Chan Chen et al.

CLINICA CHIMICA ACTA (2019)

Review Cardiac & Cardiovascular Systems

Bilirubin acts as a multipotent guardian of cardiovascular integrity: more than just a radical idea

Andrew C. Bulmer et al.

AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2018)

Article Cardiac & Cardiovascular Systems

Mild hyperbilirubinaemia as an endogenous mitigator of overweight and obesity: Implications for improved metabolic health

Nazlisadat Seyed Khoei et al.

ATHEROSCLEROSIS (2018)

Review Endocrinology & Metabolism

Bilirubin in the Liver-Gut Signaling Axis

Abdul-Rizaq Hamoud et al.

TRENDS IN ENDOCRINOLOGY AND METABOLISM (2018)

Article Multidisciplinary Sciences

Bilirubin Binding to PPARα Inhibits Lipid Accumulation

David E. Stec et al.

PLOS ONE (2016)

Article Medical Laboratory Technology

Increased large VLDL and small LDL particles are related to lower bilirubin in Type 2 diabetes mellitus

Robin P. F. Dullaart et al.

CLINICAL BIOCHEMISTRY (2014)

Article Medicine, Research & Experimental

PPARα: A Master Regulator of Bilirubin Homeostasis

Cyril Bigo et al.

PPAR RESEARCH (2014)

Review Pharmacology & Pharmacy

Heme in pathophysiology: a matter of scavenging, metabolism and trafficking across cell membranes

Deborah Chiabrando et al.

FRONTIERS IN PHARMACOLOGY (2014)

Article Gastroenterology & Hepatology

Association of Serum Bilirubin with Aging and Mortality

Brigid S. Boland et al.

JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY (2014)

Article Cardiac & Cardiovascular Systems

Cardiovascular Events as a Function of Serum Bilirubin Levels in a Large, Statin-Treated Cohort

Laura J. Horsfall et al.

CIRCULATION (2012)

Review Pharmacology & Pharmacy

The role of bilubinin diabetes, metabolic syndrome, and cardiovascular diseases

Libor Vitek

FRONTIERS IN PHARMACOLOGY (2012)

Article Medical Laboratory Technology

Decreased small dense LDL levels in Gilbert's syndrome

Serkan Tapan et al.

CLINICAL BIOCHEMISTRY (2011)

Review Public, Environmental & Occupational Health

Association Between Heme Oxygenase-1 Gene Promoter Polymorphisms and Type 2 Diabetes Mellitus: A HuGE Review and Meta-Analysis

Wei Bao et al.

AMERICAN JOURNAL OF EPIDEMIOLOGY (2010)

Article Geriatrics & Gerontology

Heme oxygenase 1 expression in rat liver during ageing and ethanol intoxication

Stefania Patriarca et al.

BIOGERONTOLOGY (2007)

Article Cardiac & Cardiovascular Systems

Bilirubin and coronary heart disease risk in the Prospective Epidemiological Study of Myocardial Infarction (PRIME)

Judith A. Troughton et al.

EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION (2007)

Review Cardiac & Cardiovascular Systems

Heme oxygenase-1 - A novel drug target for atherosclerotic diseases?

Roland Stocker et al.

CIRCULATION (2006)

Review Biochemistry & Molecular Biology

The role of heme oxygenase-1 promoter polymorphisms in human disease

M Exner et al.

FREE RADICAL BIOLOGY AND MEDICINE (2004)

Article Medicine, Research & Experimental

Inverse relationship between serum bilirubin and atherosclerosis in men:: A meta-analysis of published studies

L Novotny et al.

EXPERIMENTAL BIOLOGY AND MEDICINE (2003)

Article Cell Biology

Age-dependent increase of heme oxygenase-1 gene expression in the liver mediated by NFκB

Y Lavrovsky et al.

MECHANISMS OF AGEING AND DEVELOPMENT (2000)